Bleeding risk in patients with acute coronary syndrome in a Turkish population: Results from the Turkish Acute Coronary Syndrome Registry (TACSER) study
- 27 June 2020
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 50 (11), e13271
- https://doi.org/10.1111/eci.13271
Abstract
Objective Bleeding is one of the most important causes of mortality in patients with acute coronary syndrome (ACS). This study therefore aimed to investigate bleeding risk in patients with ACS who were scheduled to receive dual antiplatelet therapy (DAPT) in Turkey. Methods This was a multicentre, observational, cross‐sectional cohort study. The study population included 963 patients with ACS from 12 centres in Turkey. We used the Predicting Bleeding Complication in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE‐DAPT) score to predict the bleeding risk for all the patients. The patients were divided into high (≥25) or low (˂25) bleeding risk groups based on their PRECISE‐DAPT scores. Results The mean PRECISE‐DAPT score was 21.9. Overall, 32.2% of the patients had high PRECISE‐DAPT scores (≥25). Compared with the male patients, the female patients had higher PRECISE‐DAPT scores (28.2 ± 15.7 vs 18.4 ± 13.6, P ˂ .001). Among the females, the rate of patients with a PRECISE‐DAPT score ≥25 was 53%, while among the male patients, the score occurred at a rate of 22%. The female patients had lower haemoglobin (Hb) levels than the male patients (12.1 ± 1.7 vs 13.8 ± 1.9, P ˂ .001) and lower creatinine clearance (70.7 ± 27.5 vs 88.7 ± 26.3, P ˂ .001). The in‐hospital bleeding rates were higher among the patients with high PRECISE‐DAPT scores than among those who did not have high scores. Furthermore, the patients with high PRECISE‐DAPT scores had a higher in‐hospital mortality rate compared with those with low PRECISE‐DAPT scores (1% vs 0%, P = .11). Conclusions The mean PRECISE‐DAPT score was high among the patients with ACS in this study, indicating that the bleeding tendency was high. This study showed that the PRECISE‐DAPT score may help physicians determine the type and duration of DAPT, especially in patients with ACS in Turkey.Keywords
This publication has 31 references indexed in Scilit:
- A population-based survey of Chronic REnal Disease In Turkey--the CREDIT studyNephrology Dialysis Transplantation, 2010
- A Risk Score to Predict Bleeding in Patients With Acute Coronary SyndromesJournal of the American College of Cardiology, 2010
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2009
- In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents: A Report From the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) RegistryJACC: Cardiovascular Interventions, 2009
- Reliability of GFR formulas based on serum creatinine, with special reference to the MDRD Study equationScandinavian Journal of Clinical and Laboratory Investigation, 2008
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2007
- Bleeding Complications in Patients With Anemia and Acute Myocardial InfarctionThe American Journal of Cardiology, 2005
- Increased platelet phosphatidylserine exposure and caspase activation in chronic uremiaJournal of Thrombosis and Haemostasis, 2004
- Reduced Platelet Thromboxane Formation in Uremia. EVIDENCE FOR A FUNCTIONAL CYCLOOXYGENASE DEFECTJCI Insight, 1983